Neoadjuvant Therapy: When Should It Be Used for Pancreatic Cancer?

TY - JOUR

T1 - Neoadjuvant Therapy: When Should It Be Used for Pancreatic Cancer?

AU - Kelly, Kristin N.

AU - Macedo, Francisco I.

AU - Merchant, Nipun B.

N1 - @inbook{f89b698eb3fc419da00b0bbf2913f33d, title = "Neoadjuvant Therapy: When Should It Be Used for Pancreatic Cancer?", keywords = "Borderline resectable pancreatic cancer, CA 19-9, FOLFIRINOX, Gemcitabine-abraxane, Locally advanced pancreatic cancer, Neoadjuvant chemotherapy, Portal vein resection, Whipple procedure", author = "Kelly, {Kristin N.} and Macedo, {Francisco I.} and Merchant, {Nipun B.}", note = "Funding

PY - 2020/6/24

Y1 - 2020/6/24

UR - https://miami.pure.elsevier.com/en/publications/neoadjuvant-therapy-when-should-it-be-used-for-pancreatic-cancer

U2 - 10.1016/J.YASU.2020.05.001

DO - 10.1016/J.YASU.2020.05.001

M3 - Article

VL - 54

JO - Advances in Surgery

JF - Advances in Surgery

ER -